Horizon Pharma Talks to Depomed Holders About Adding Cash

Updated on

Horizon Pharma Plc is talking to Depomed Inc. shareholders about a revised takeover offer that would include as much as 25 percent in cash, though the total value of the proposal would be lower than its current all-stock bid.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.